// App-Quantinova.ai

: Improvements in Clinical Outcomes Associated with Reduction in Hyperinflation with Zephyr Valves

Researchers

Presenter

  • Frank Sciurba

Principal Investigators

  • Richard Sue

  • Hiram Rivas-Perez

  • Brian Morrissey

  • Hugo Goulart De Oliveira

  • Momen Wahidi

  • Paulo F G Cardoso

  • Nicholas Pastis Jr

  • Mark Dransfield

  • Pallav Shah

  • Sri Radhakrishnan

  • Narinder Shargill

  • Gerard Criner

  • Dirk-Jan Slebos

Medical Centers

  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States

  • St. Joseph’s Hospital and Medical Center, Phoenix, United States of America

  • University of Louisville School of Medicine, Louisville, United States of America

  • UC Davis School of Medicine Sacramento CA United States

  • Universidade Federal do Rio Grande do Sul, Hospital de Clinicas of Porto Alegre, Porto Alegre, Brazil

  • Duke University School of Nursing, Durham, United States of America

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • Medical University of South Carolina, Charleston, United States of America

  • University of Alabama at Birmingham UAB Lung Health Center, Birmingham, United States of America

  • Royal Brompton Hospital and Imperial College, London, United Kingdom

  • Pulmonx Corporation, Redwood City, United States of America

  • Lewis Katz School of Medicine at Temple University, Philadelpha , United States of America

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

Locations

  • United States

  • Brazil

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A